SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-004949
Filing Date
2021-04-26
Accepted
2021-04-26 16:45:17
Documents
8

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2005178
2 GRAPHIC g155225g11d11.jpg GRAPHIC 132129
3 GRAPHIC g155225g13a00.jpg GRAPHIC 120926
4 GRAPHIC g155225g22z92.jpg GRAPHIC 112079
5 GRAPHIC g155225g36n42.jpg GRAPHIC 316344
6 GRAPHIC g155225g80r72.jpg GRAPHIC 178075
7 GRAPHIC g155225g92x08.jpg GRAPHIC 44812
8 GRAPHIC g155225g93a99.jpg GRAPHIC 106545
  Complete submission text file 0000950123-21-004949.txt   3391561
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-04729 | Film No.: 21854475
SIC: 2834 Pharmaceutical Preparations